Tus kws kho mob
Kerendia® - Commercial - Effective Date 03/01/2025
Step Therapy, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1791 - 1800 ntawm 3685
Tus kws kho mob
Interstitial Lung Disease (ILD) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Interleukin-5 (IL-5) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Arikayce® (amikacin liposome inhalation) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Antifungals - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Antifungals - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2025
Tus kws kho mob
QP32-22 Commercial Pharmacy Benefit Exclusion for EnjaymoTM
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tus kws kho mob
QP33-22 MHCP Pharmacy Benefit Exclusion for CarvyktiTM and EnjaymoTM
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tus kws kho mob
QP34-22 Minnesota Senior Health Options (MSHO) Model of Care: Annual Training Requirement Reminder
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tus kws kho mob
QP35-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 14, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022